Drug
Gen1079
Gen1079: highest development phase Phase 1, developed by Genmab. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Genmab
Trials
| Drug | Phase | Indication |
|---|---|---|
| GEN1079 NCT07387068 | Phase 1 | Advanced Solid Tumors |
Latest
No recent events.
Follow Gen1079 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.